From: Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging
Volumetric imaging | Visibility (CNR) | Â | Artefact (SI) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RP | CIVCO | GA | GA (B) | PM | Â | RP | CIVCO | GA | GA(B) | PM | |
CT (slice thickness (mm)) | |||||||||||
 0.625 | 1.46 | 1.49 | 1.53 | 1.54 | 1.47 |  | 67.78 | 110.9 | 61.04 | 67.51 | 25.57 |
 1.25 | 1.61 | 1.46 | 1.44 | 1.22 | 1.52 |  | 86.92 | 52.81 | 65.20 | 59.64 | 66.24 |
 2.5 | 1.27 | 1.23 | 1.42 | 1.34 | 1.52 |  | 53.35 | 47.19 | 36.88 | 46.15 | 11.63 |
CBCT (protocol) | |||||||||||
 P Varian | 1.17 | 0.96 | 0.99 | 0.92 | 0.79 |  | 33.16 | 22.03 | 33.81 | 13.86 | 19.55 |
 P Medium | 0.94 | 0.94 | 0.64 | 1.07 | 0.90 |  | 26.38 | 42.57 | 15.58 | 19.91 | 9.82 |
 P Obese | 1.00 | 0.84 | 0.85 | 1.16 | 1.27 |  | 66.08 | 58.28 | 47.48 | 75.81 | 36.88 |
MRI | FM size (mm3) | ||||||||||
 | P | 13.57 | 13.57 | 5.03 | 5.03 | 9.42 | |||||
 T1w | 1.17 | 1.69 | 1.77 | 1.64 | 2.56 |  | 6.67 | 10.00 | 6.67 | 26.67 | 3.33 |
 T2w (filtered) | 1.95 | 1.87 | 1.54 | 1.45 | 1.88 |  | 13.33 | 20.00 | 16.67 | 23.33 | 13.33 |
 VIBE | 1.58 | 1.94 | 1.57 | 1.47 | 2.10 |  | 53.33 | 70.0 | 123.33 | 136.67 | 110.00 |